No description available.

No description available.

Made available in DSpace on 2016-07-18T17:53:17Z (GMT). No. of bitstreams: 1 Francislaine.pdf: 394781 bytes, checksum: a0d56232957fee86543512d568bcec4c (MD5) Previous issue date: 2015-12-18 / Tea is an extremely popular drink, being the second most commonly consumed in the world. People ingest teas on average two to three times a day, the majority being derived from the Camellia sinensis plant. The beneficial health effects of the consumption of tea from this plant are well known, such as the prevention of cancer, cardiovascular disease and osteoporosis. Despite this, little is known about the action of white tea on reproduction. It is important to evaluate the possible consequences of consumption on luteal and endometrial development since the main catechin, epigallocatechin gallate (EGCG), present in the tea influences the gene expression of VEGF in tumors and this is an important angiogenic factor in the reproductive organs. This study aimed to verify the effects of prolonged intake of white tea on the relative abundance of VEGF mRNA and its receptors, as well as in cell proliferation in the endometrium of superovulated rats. For this purpose, the rats were divided into two groups, control group (n = 30), which received water, and white tea intake group (n = 30). The ovaries and uteri were collected from 10 animals in each group at the end of every month, for three consecutive months, stored in Trizol in a freezer at -80 ° C and the relative abundance of VEGF mRNA, Flt-1 and KDR were subsequently evaluated. In addition, the uteri were histologically analyzed using the silver staining method to detect cell proliferation. The data were evaluated for the assumption of normality (Shapiro-Wilk) and statistical comparisons were performed using the unpaired t test between groups at different collection moments (p <0.05). The relative abundance of VEGF mRNA and its receptors was changed by the tea consumption and there were a lower number of nucleolar organizer regions in endometrial cells. It was concluded that prolonged consumption of white tea interferes the expression of the VEGF system genes in the corpus luteum and decreases cell proliferation in the endometrium of Wistar rats. / O chá é uma das bebidas mais populares e a segunda mais consumida no mundo. A população ingere chás em média, de duas a três vezes ao dia, sendo em sua maioria oriundos da planta Camellia sinensis. São bem conhecidos os efeitos benéficos para a saúde do consumo dos chás provenientes dessa planta, como a prevenção de câncer, de doença cardiovascular e da osteoporose. Apesar disso, pouco se sabe sobre a ação do chá branco na reprodução, sendo importante avaliar as possíveis consequências do seu consumo no desenvolvimento luteal e endometrial. Visto que a principal catequina, a epigalocatequina galato (EGCG) presente neste chá influencia a expressão gênica do Vegf em tumores e este é um importante fator angiogênico dos órgãos reprodutivos, este estudo teve como objetivo verificar o efeito da ingestão do chá branco sobre a abundância relativa do mRNA do Vegf e dos seus receptores,sobre a proliferação celular do endométrio de ratas superovuladas. Para tanto, as ratas foram distribuídas em dois grupos, grupo controle (n=30) que recebeu água e grupo com ingestão de chá branco (n=30). Os ovários e os úteros foram coletados ao final de cada mês de ingestão de chá branco ou água de 10 animais de cada grupo, durante três meses consecutivos, sendo os ovários armazenados em trizol no freezer a -80ºC e posteriormente a abundância relativa de mRNA do Vegf, do Flt-1 e do Kdr foram avaliadas. Além disso, os úteros foram analisados histologicamente pelo método de coloração de prata para detecção de proliferação celular. Os dados foram avaliados quanto ao pressuposto de normalidade (Shapiro-Wilk) e as comparações estatísticas foram realizadas por meio dos testes t não pareado entre os grupos nos diferentes momentos de colheitas (p<0,05). A abundância relativa de mRNA do Vegf e dos seus receptores foi alterada pelo consumo de chá e houve um menor número de regiões organizadoras de nucléolo nas células do endométrio. Conclui-se que a ingestão prolongada de chá branco altera a expressão dos genes do sistema Vegf no corpo lúteo e diminui a proliferação celular do endométrio de ratas Wistar.

Einleitung: Die Dysbalance proangiogener (Placental Growth Factor = PlGF) und antiangiogener Faktoren (soluble fms-like tyrosine kinase 1 = sFlt-1) gilt heute als pathophysiologische Grundlage bei der Entstehung einer Präeklampsie (PE), eines HELLP-Syndroms (Haemolysis, Elevated Liver enzymes, Low Platelets) oder einer intrauterinen Wachstumsretardierung (IUGR). Der sFlt1/PlGF-Quotient, ein sensitiver und robuster diagnostischer Marker, ist bereits Wochen vor der Krankheitsmanifestation erhöht. Ziel dieser Studie war es, die Wertigkeit des sFlt1/PlGFQuotienten als prädiktiven Faktor bei Risikopatientinnen zu untersuchen. Patienten und Methode: In diese prospektive Studie wurden 68 Patientinnen mit einer Einlingsschwangerschaft und mindestens einem Risikofaktor für das Auftreten einer PE, eines HELLP-Syndrom oder einer IUGR im Schwangerschaftsverlauf eingeschlossen. Die Patientinnen wurden je nach Verlauf der Schwangerschaft in eine Gruppe mit Symptomen (Fallgruppe) und eine Gruppe ohne Symptome (Kontrollgruppe) für eine der oben genannten Erkrankungen unterteilt. Der sFlt1/PlGF-Quotient wurde bei der Aufnahme in die Studie und im weiteren Schwangerschaftsverlauf bestimmt. Ergebnisse: Eine PE, ein HELLP-Syndrom oder eine IUGR trat bei 41 % der Risikopatientinnen auf… Der absolute Wert des sFlt-1/PlGF-Quotienten war nur bei der Gruppe mit Symptomen auf ≥ 85 erhöht und zeigte sich in der 25 + 0-31 + 0 SSW (p = 0,005) und ab der 35 + 0 SSW (p = 0,044) als prädiktiver Faktor für eine PE, ein HELLP-Syndrom oder eine IUGR. Ab 7–10 Wochen vor der Entbindung war, in der Fallgruppe stärker als in der Kontrollgruppe, ein Anstieg des sFlt1/PlGFQuotienten zu beobachten. Dieser war 0–2 Wochen vor der Entbindung bei beiden Gruppen (Kontrollgruppe (MW ± SA 66,9 ± 134) vs. Fallgruppe (MW ± SA 393,3 ± 147,4, p = 0,021) am ,stärksten und zeigte sich ebenfalls als prädiktiver Faktor für eine der genannten Schwangerschaftserkrankungen (p = 0,025). Schlussfolgerung: Bei Risikoschwangeren kann der sFlt1/ PlGF-Quotient für die Einschätzung des individuellen Risikos für eine PE, ein HELLP-Syndrom oder eine IUGR im Schwangerschaftsverlauf genutzt werden. Wiederholte Messungen des Quotienten versprechen eine risikoangepasste Betreuung dieser Patientinnen. / Background: A dysbalance of proangiogenic [placental growth factor (PlGF)] and antiangiogenic [soluble fms-like tyrosine kinase 1 (sFlt-1)] proteins is known to cause the symptoms of preeclampsia (PE), HELLP syndrome (hemolysis, elevated liver enzymes, low platelets) or intrauterine growth restriction (IUGR). An increased sFlt-1/ PlGF ratio ≥ 85 is considered a reliable diagnostic marker. Altered sFlt1 and PlGF concentrations can be detected several weeks prior to the onset of clinical symptoms. In this study we analysed the role of the sFlt1/PlGF ratio as a predictive marker for preeclampsia in a high-risk patient group. Patients and materials: We prospectively included 68 singleton pregnancies with at least one risk factor for PE, HELLP syndrome or IUGR. During the study the patients were divided into one group with symptoms (patient group) and one group without symptoms (control group) for the above-mentioned diseases. The sFlt1/PlGF ratios were measured on admission and during the course of pregnancy. Results: During pregnancy 41 % of patients developed PE, HELLP syndrome or IUGR. An increase of the absolute value of the sFlt1/PlGF ratio ≥ 85 was only observed in the patient group and was found to be a predictive factor for PE, HELLP syndrome or IUGR at 25 + 0 to 31 + 0 weeks of gestation (p = 0.005) and after 35 + 0 weeks of gestation (p = 0.044). Alterations of the sFlt1/PlGF ratio were observed in all patients but were higher in the patient group from 7–10 weeks prior to delivery and with the highest peak 0–2 weeks prior to delivery. Compared to the control group (mean ± SD 66.9 ± 134) absolute values of sFlt1/PlGF ratio were signifi cantly (p = 0.021) increased 0–2 weeks prior to delivery in the patient group (mean ± SD 393.3 ± 147.4). An increase of the sFlt1/PlGF ratio ≥ 85 0–2 weeks before delivery has shown to be predictive for one of the mentioned diseases (p = 0.025).Conclusions: In high-risk patients the sFlt1/PlGF ratio can be used for an individual risk assessment with regard to PE, HELLP syndrome or IUGR. Serial measurements permit a risk-adapted prenatal care of these patients.

Vascular endothelial growth factor (VEGF) is a potent angiogenic agent. VEGF activates its biologic responses through two cell-surface receptors, Flt1 and Flk1. In addition to the transmembrane form of Flt1, the Flt1 gene also encodes a secreted, truncated form of the receptor (sFlt1) translated from an mRNA in which a portion of intron 13 is preserved. sFlt1 retains high affinity for VEGF and thereby inhibits its angiogenic activity. Intron 13 contains important cis elements involved in sFlt1 mRNA formation. Here, we test the hypothesis that polymorphisms in the human Flt1 gene, particularly SNPs at sites suspected to contain splicing or cleavage-polyadenylation signals, influence Flt1 pre-mRNA processing and rates of Flt1 and sFlt1 expression. The NCBI SNP database contained 23 SNPs in the region of interest, one each in exons 13 and 14. An independent human SNP screen confirmed several of the reported SNPs. The web-based ESEfinder software predicted that the exon 13/14 SNPs had reduced potential for recruitment of splicing components. To test effects of exonic SNPs on Flt1 pre-mRNA processing, wild type and mutant Flt1 minigene plasmids were transfected into NIH/3T3 cells. Both exonic SNPs were associated with ~40% decreases in Flt1:sFlt1 mRNA ratios determined by real-time PCR. To facilitate exploration of ESEs in regulated RNA splicing, a PERL computer program, "EXONerator" was written to silence predicted ESEs without altering polypeptide sequence. These results support the notion that small changes in exon composition can have significant effects on splicing activity and underscore the utility of software tools for hypothesis generation. / Ph. D.

Angiogenesis is the formation of new blood vessels from existing vasculature. Vascular Endothelial Growth Factor (VEGF), a known angiogenic protein, stimulates endothelial cell proliferation and migration via interactions with its receptors, KDR and Flt-1. A secreted form of Flt-1 (sFlt-1), derived from alternatively-spliced RNA, can inhibit actions of VEGF in vivo. It has been suggested that alterations in sFlt-1 expression could significantly change the angiogenic VEGF activity. This project focuses on characterizing intronic elements that regulate Flt-1 mRNA splicing. A "wild-type" construct (pFIN13), containing the first 13 exons, intron 13 and exons 14-30 of mouse Flt-1, was shown to produce both forms of Flt-1 mRNA after transfection into HEK293 cells. To gauge the strength of the native splicing signals in intron 13 of Flt-1, a series of point mutations were made in the polypyrimidine tract using pFIN13. After transient transfection, the levels of Flt-1 and sFlt-1 protein and mRNA were compared using quantitative PCR, RNA hybridization analysis, and protein immunoblotting. Results from quantitative PCR showed that purine substitutions were associated with 120 to 350 fold decreases in Flt-1 mRNA (normalized against neor), consistent with less efficient splicing. These large decreases in Flt-1 mRNA were accompanied by increases in sFlt-1 mRNA. Modest (20 to 100%) increases in Flt-1 mRNA, reflecting improved splicing, resulted from increasing the uridine complement in the polypyrimidine tract. These results suggest that the wild-type polypyrimidine tract is of intermediate strength and may be a regulatory locus for modulating Flt-1: sFlt-1 ratios. / Master of Science

Submitted by (edna.saturno@ufrpe.br) on 2016-07-25T12:46:12Z No. of bitstreams: 1 Natalie Emanuelle Ribeiro e Silva.pdf: 562491 bytes, checksum: e2fc3bb4739adc151a9f70d9d8e255e1 (MD5) / Made available in DSpace on 2016-07-25T12:46:12Z (GMT). No. of bitstreams: 1 Natalie Emanuelle Ribeiro e Silva.pdf: 562491 bytes, checksum: e2fc3bb4739adc151a9f70d9d8e255e1 (MD5) Previous issue date: 2013-02-26 / Coordenação de Aperfeiçoamento de Pessoal de Nível Superior - CAPES / Intrauterine programmed cardiovascular disease may be linked to placental oxidative stress. It was investigated whether NaCl supplement, during pregnancy, affects placental oxidative stress and angiogenesis and imprints increased levels of oxidative stress in fetal liver. Dams were treated with 1.8% NaCl in drinking water from 20 days before and along pregnancy. Along pregnancy α-tocopherol, tempol or both were administered. Angiogenesis was evaluated throughout the expression of flt-1, the type 1 receptor for VEGF, in the villous bundles/labirinth. NaCl diminished flt-1 expression, as well as, reduced malonyldialdehide and augmented reduced gluthatione in placenta and fetal liver. α-Tocopherol led to an additional reduction in MDA levels in these organs, but diminished GSH. Otherwise, tempol increased MDA and diminished GSH in both placenta and fetal liver. No antioxidant changed the expression of flt-1. The reduced levels of MDA in placenta and fetal liver of dams under NaCl supplement might be due to reduced angiogenesis, that reduced oxygen supply, and also to the increased GSH levels. However the paradoxical pro-oxidant action of tempol indicates that the antioxidant reservoir in dams under sodium overload is limited. Furthermore, the parallel between the pattern of placental and fetal liver oxidative stress suggests that superoxide anions transferred from mothers may be important in programming cardiovascular diseases. / Doenças cardiovaculares programadas intrauterinamente podem está ligadas ao estresse oxidativo placentário. Neste trabalho, investigamos se a sobrecarga de NaCl, durante a gravidez, afeta o estresse oxidativo e angiogênese placentária, bem como se afeta os níveis de estresse oxidativo no fígado do feto. Mães foram tratadas com NaCl, 1,8%, na água de beber, 20 dias antes e ao longo da gravidez. α-Tocoferol, tempol ou ambos foram administrados ao longo da gravidez. A angiogênese foi avaliada por meio da expressão do flt-1, o receptor tipo 1 para o VEGF, nos feixes vilosos do labrinto. A suplementação com NaCl diminuiu a expressão de flt-1, bem como, reduziu os níveis de malonildialdeido e aumentou os níveis de glutationa reduzida na placenta e no fígado fetal. O α-tocoferol levou a uma redução adicional nos níveis de MDA nesses órgãos, mas diminuiu os níveis de GSH. De maneira diferente, o tempol aumentou os níveis de MDA e diminuiu os níveis de na placenta e no fígado fetal. O tratamento com os antioxidantes não alterou a expressão do flt-1. Os níveis reduzidos de MDA na placenta e no fígado do feto de mães submetidas a sobrecarga de NaCl podem ser devidos à angiogênese diminuida, o que reduziu o suprimento de oxigênio, ou aos os níveis aumentados de GSH. Entretanto, a ação paradoxal, pro-oxidante, do tempol indica que a reserva antioxidante nas mães submetidas a sobrecarga de sódio é limitada. Além disso, o paralelo entre o padrão de estresse oxidativo placentário e do fígado fetal sugere que ânions superóxidos transferidos a partir das mães podem ser importantes na programação das doenças cardiovaculares.

Einleitung: Die Dysbalance proangiogener (Placental Growth Factor = PlGF) und antiangiogener Faktoren (soluble fms-like tyrosine kinase 1 = sFlt-1) gilt heute als pathophysiologische Grundlage bei der Entstehung einer Präeklampsie (PE), eines HELLP-Syndroms (Haemolysis, Elevated Liver enzymes, Low Platelets) oder einer intrauterinen Wachstumsretardierung (IUGR). Der sFlt1/PlGF-Quotient, ein sensitiver und robuster diagnostischer Marker, ist bereits Wochen vor der Krankheitsmanifestation erhöht. Ziel dieser Studie war es, die Wertigkeit des sFlt1/PlGFQuotienten als prädiktiven Faktor bei Risikopatientinnen zu untersuchen. Patienten und Methode: In diese prospektive Studie wurden 68 Patientinnen mit einer Einlingsschwangerschaft und mindestens einem Risikofaktor für das Auftreten einer PE, eines HELLP-Syndrom oder einer IUGR im Schwangerschaftsverlauf eingeschlossen. Die Patientinnen wurden je nach Verlauf der Schwangerschaft in eine Gruppe mit Symptomen (Fallgruppe) und eine Gruppe ohne Symptome (Kontrollgruppe) für eine der oben genannten Erkrankungen unterteilt. Der sFlt1/PlGF-Quotient wurde bei der Aufnahme in die Studie und im weiteren Schwangerschaftsverlauf bestimmt. Ergebnisse: Eine PE, ein HELLP-Syndrom oder eine IUGR trat bei 41 % der Risikopatientinnen auf… Der absolute Wert des sFlt-1/PlGF-Quotienten war nur bei der Gruppe mit Symptomen auf ≥ 85 erhöht und zeigte sich in der 25 + 0-31 + 0 SSW (p = 0,005) und ab der 35 + 0 SSW (p = 0,044) als prädiktiver Faktor für eine PE, ein HELLP-Syndrom oder eine IUGR. Ab 7–10 Wochen vor der Entbindung war, in der Fallgruppe stärker als in der Kontrollgruppe, ein Anstieg des sFlt1/PlGFQuotienten zu beobachten. Dieser war 0–2 Wochen vor der Entbindung bei beiden Gruppen (Kontrollgruppe (MW ± SA 66,9 ± 134) vs. Fallgruppe (MW ± SA 393,3 ± 147,4, p = 0,021) am ,stärksten und zeigte sich ebenfalls als prädiktiver Faktor für eine der genannten Schwangerschaftserkrankungen (p = 0,025). Schlussfolgerung: Bei Risikoschwangeren kann der sFlt1/ PlGF-Quotient für die Einschätzung des individuellen Risikos für eine PE, ein HELLP-Syndrom oder eine IUGR im Schwangerschaftsverlauf genutzt werden. Wiederholte Messungen des Quotienten versprechen eine risikoangepasste Betreuung dieser Patientinnen.:1. BIBLIOGRAFISCHE BESCHREIBUNG 2 2. EINFÜHRUNG 3 2.1. Allgemeines 3 2.2. Klassifikationen 3 2.3. Risikofaktoren 5 2.4. Neue molekulare Erkenntnisse: angiogene Faktoren 6 2.5. Klinische Studien 7 2.6. Differentialdiagnostik anhand angiogener Faktoren 11 2.7. Die Methode für die automatisierte Messung 12 2.8. Die Bedeutung der Dopplersonografie 12 2.9. Weitere Marker und First-Trimester-Screening 13 2.10. Prävention 14 3. PUBLIKATIONSMANUSKRIPT Die Wertigkeit des sFlt-1/PlGF-Quotienten als Prädiktionsparameter bei Schwangeren mit erhöhtem Präeklamsierisiko......................................................15 4. ZUSAMMENFASSUNG DER ARBEIT 22 5. ANLAGEN 27 5.1. Literaturverzeichnis 27 5.2. Erklärung über die eigenständige Abfassung der Arbeit 332 5.3. Lebenslauf 33 5.4. Danksagung 35 / Background: A dysbalance of proangiogenic [placental growth factor (PlGF)] and antiangiogenic [soluble fms-like tyrosine kinase 1 (sFlt-1)] proteins is known to cause the symptoms of preeclampsia (PE), HELLP syndrome (hemolysis, elevated liver enzymes, low platelets) or intrauterine growth restriction (IUGR). An increased sFlt-1/ PlGF ratio ≥ 85 is considered a reliable diagnostic marker. Altered sFlt1 and PlGF concentrations can be detected several weeks prior to the onset of clinical symptoms. In this study we analysed the role of the sFlt1/PlGF ratio as a predictive marker for preeclampsia in a high-risk patient group. Patients and materials: We prospectively included 68 singleton pregnancies with at least one risk factor for PE, HELLP syndrome or IUGR. During the study the patients were divided into one group with symptoms (patient group) and one group without symptoms (control group) for the above-mentioned diseases. The sFlt1/PlGF ratios were measured on admission and during the course of pregnancy. Results: During pregnancy 41 % of patients developed PE, HELLP syndrome or IUGR. An increase of the absolute value of the sFlt1/PlGF ratio ≥ 85 was only observed in the patient group and was found to be a predictive factor for PE, HELLP syndrome or IUGR at 25 + 0 to 31 + 0 weeks of gestation (p = 0.005) and after 35 + 0 weeks of gestation (p = 0.044). Alterations of the sFlt1/PlGF ratio were observed in all patients but were higher in the patient group from 7–10 weeks prior to delivery and with the highest peak 0–2 weeks prior to delivery. Compared to the control group (mean ± SD 66.9 ± 134) absolute values of sFlt1/PlGF ratio were signifi cantly (p = 0.021) increased 0–2 weeks prior to delivery in the patient group (mean ± SD 393.3 ± 147.4). An increase of the sFlt1/PlGF ratio ≥ 85 0–2 weeks before delivery has shown to be predictive for one of the mentioned diseases (p = 0.025).Conclusions: In high-risk patients the sFlt1/PlGF ratio can be used for an individual risk assessment with regard to PE, HELLP syndrome or IUGR. Serial measurements permit a risk-adapted prenatal care of these patients.:1. BIBLIOGRAFISCHE BESCHREIBUNG 2 2. EINFÜHRUNG 3 2.1. Allgemeines 3 2.2. Klassifikationen 3 2.3. Risikofaktoren 5 2.4. Neue molekulare Erkenntnisse: angiogene Faktoren 6 2.5. Klinische Studien 7 2.6. Differentialdiagnostik anhand angiogener Faktoren 11 2.7. Die Methode für die automatisierte Messung 12 2.8. Die Bedeutung der Dopplersonografie 12 2.9. Weitere Marker und First-Trimester-Screening 13 2.10. Prävention 14 3. PUBLIKATIONSMANUSKRIPT Die Wertigkeit des sFlt-1/PlGF-Quotienten als Prädiktionsparameter bei Schwangeren mit erhöhtem Präeklamsierisiko......................................................15 4. ZUSAMMENFASSUNG DER ARBEIT 22 5. ANLAGEN 27 5.1. Literaturverzeichnis 27 5.2. Erklärung über die eigenständige Abfassung der Arbeit 332 5.3. Lebenslauf 33 5.4. Danksagung 35